Dec. 24 at 2:34 PM
$CODX
August 2025
Recent Business Highlights:
Company remains on track to initiate clinical evaluations for all tests in Co-Dx PCR platform* pipeline before year-end, and is currently training clinical evaluation sites for enhanced COVID-19 test and expects to begin accepting trial participants imminently
https://ir.co-dx.com/2025-08-14-Co-Diagnostics,-Inc-Reports-Second-Quarter-2025-Financial-Results
With a week left in 2025, the company has commenced one out of the four clinical evaluations that were promised to begin by EOY. The reason most of us are upset here, is because the CEO Dwight Egan has a long history of fabricating timelines to hook new investors and to keep old ones on the line.
It is borderline criminal. Where are the TB, HPV and Covid 19 clinical trials? Remain on track to initiate before year end. That’s what was said, numerous times in multiple interviews and earnings.
With a week left, and holidays in between it’s not looking good.
Stock sits under $.25
